3764. Misbranding of dextro-amphetamine sulfate tablets, racemic amphetamine
sulfate tablets, Seconal Sodium capsules, and Amytal tablets. U. Si. v.
Jacob Chubat (Chubat Pharmacy). Plea of guilty. Fine of $300, plus
costs.    (F. D. C. No. 32747.   Sample Nos. 9404-L to 9409-L, incl.)
INFORMATION FILED : March 24,1952, Northern District of Illinois, against Jacob
Chubat, trading as Chubat Pharmacy, Chicago, 111.
ALLEGED SHIPMENT: On or about March 21, April 3 and 11, and May 5, 10, and
16, 1951, while quantities of dextro-amphetamine sulfate tablets, racemic am-
phetamine sulfate tablets, Seconal Sodium capsules, and Amytal tablets were
being held for sale at the Chubat Pharmacy, after shipment in interstate com-
merce, the defendant caused various quantities of the drugs to be repacked
and dispensed without a prescription, which acts resulted in the repackaged
drugs being misbranded.
NATURE OF CHARGE : Misbranding, Sections 502 (b) (1) and (2), the repackaged
drugs failed to bear labels containing the name and place of business of the
manufacturer, packer, or distributor, and an accurate statement of the quantity
of the contents; and, Section 502 (f) (1), the labeling of the repackaged drugs
failed to bear adequate directions for use.
[D. D.N.J.
Further misbranding, Section 502 (d), the Seconal Sodium capsules and
Amytal tablets contained chemical derivatives of barbituric acid, which de-
rivatives have been found to be, and by regulations designated as, habit forming,
and these drugs failed to bear labels containing the names, and quantities or
proportions of such derivatives and in juxtaposition therewith the statement
"Warning-May be habit forming."
DISPOSITION : April 14, 1952. A plea of guilty having been entered, the court
imposed a fine of $300, plus costs.